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Thank you so much! This award celebrates my 52nd year
in genetics.
When I was 17 years old, as a college sophomore, I en-
tered a new honors program in genetics at McGill—all I
wanted to do was find a way to get into medical school!
My costudent was Dorothy Warburton, and we took turns
making lunch for the faculty!
I started to work for Clarke Fraser, filing reprints and
helping with his cleft lip and palate mouse work. Every
morning, I would examine several hundred mice for vag-
inal plugs to time their gestation. I was certain that I would
be a hit on “What’s My Line!” I soon learned that I liked
human bottoms better than mouse bottoms—no wonder
I didn’t go into OB/GYN. Clarke taught me about the joys
of research and how to think critically. When I was ac-
cepted to McGill Medical School, Clarke arranged a new
program where I could do a master’s degree over the sum-
mers of medical school. I worked on the genetics of epi-
lepsy with the Metrakoses and received my M.D.C.M. and
M.Sc. degrees in 1961.
The giants in medical genetics at that time were pri-
marily internists—McKusick, Motulsky, and Neel—and I
chose to do my residency in medicine. Little did I know
that I would later become a pediatrician by adoption!
At Victor McKusick’s invitation, I went to complete my
residency at Johns Hopkins and realized what a wonderful
place it was. Victor had just started a Ph.D. program in
Human Genetics, and I was able to pursue a fellowship
and receive a Ph.D. in 3 years. Just ahead of me in the
program was Alan Emery. A decade later, we met in the
Hotel Russya in Moscow and formulated plans for “Prin-
ciples and Practice of Medical Genetics”; the fifth edition,
which includes an E edition, is being introduced at these
meetings.
Victor taught me the power of clinical research and the
value of studying rare diseases to prove basic biological
principles. I accompanied him to meetings of the Little
People of America (LPA) and even the “freak show” at the
Barnum and Bailey circus at Madison Square Garden to
find new research subjects.
He also highlighted the conflict between the “lumpers”
and “splitters.” We now know that both sides are correct—
the splitters demonstrating enormous locus and allelic het-
erogeneity and the lumpers showing that the same phe-
notype can be produced by different genes that operate
on the same pathway. This demonstrates the tremendous
need for clinicians and lab scientists to work collabora-
tively. Not only can genotyping without phenotyping lead
to missense or nonsense, but phenotyping without ge-
notyping can also result in inappropriate prognostication,
counseling, and treatment.
While doing a consult on the wards at Johns Hopkins,
I saw a little person who looked just like a pituitary dwarf,
but she was sexually mature and had a normal daughter.
However, up until that time, there was no growth-hor-
mone assay, and it was thought that all pituitary dwarfs
were hypogonadal. Tom Merimee had just returned from
the Berson and Yalow lab, and, with the new human-
growth-hormone (HGH) immunoassay, we demonstrated
that isolated growth-hormone deficiency did exist. These
patients reminded me of the National Geographic pictures
I had seen of pygmies, and Victor contacted Luca Cavalli-
Sforza, who was doing population-genetics studies in the
Central African Republic. I joined Luca’s team on three
occasions, and we showed that the pygmies were resistant
to HGH or IGF1. My daughter Anne is an epidemiologist
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who is currently studying monkeypox in the Congo, and
she plans to collect pygmy DNA so that we can now search
for their molecular defect.
When I would go to LPA meetings looking for more
growth hormone–deficient dwarfs, the disproportionate
ones complained that I was ignoring them. I realized how
little was known about their biology and gradually switched
my interests.
I was recruited to Washington University in St. Louis to
start the genetics clinic, where I was able to jump start my
independent research career. I created the International
Skeletal Dysplasia Registry, which still provides samples
for our molecular research, almost 40 years later!
I soon realized that I wanted to develop my own ge-
netics program, and, after exploring many possibilities in
more-traditional university settings, I ended up choosing
Harbor General Hospital, a county hospital with World
War II barracks converted into labs. I received an RO1
grant for my skeletal dysplasia work, and the National
Institutes of Health (NIH) support for this project has
lasted 36 years to date.
I was extremely fortunate to recruit Mike Kaback to join
me, and I helped him start the California Tay-Sachs screen-
ing program, which became the prototype for genetic-
disease prevention. We were able to “Shanghai” my former
student, Larry Shapiro, on his way back to St. Louis from
the NIH, and he accepted a faculty position at Harbor and
quickly became a leader in the field. Jerry Rotter was one
our own graduates to join the faculty. A number of these
Harbor graduates became leaders in cartilage biology, in-
cluding David Hollister, Ilkka Kaitila, William Horton, and
David Sillence.
My first national leadership position was as national
secretary-treasurer of the American Federation of Clinical
Research (AFCR) (now the AFMR), and I helped run the
national clinical research meetings in Atlantic City. I was
then elected president of the Western Society for Clinical
Research, which ran the annual meetings in Carmel, and,
20 years later, I became president of the Western Society
for Pediatric Research.
In the late ’70s, ASHG President Arno Motulsky asked
me to form a committee to look into credentialing medical
geneticists and accrediting training programs. I was able
to put together a committee of the giants in field—and
we created the American Board of Medical Genetics. Since
the American Board of Medical Specialties (ABMS) was not
admitting any new Boards at the time, in order to make
the new ABMG credible, we hired the National Board of
Medical Examiners (NBME) to administer the exams. Af-
ter the first exam, we asked the new ABMG diplomats
whether our original Board could be grandfathered in,
and, much to our dismay, they voted no—so almost all
of us took the next exam.
In the mid-1980s, I was elected president of the ASHG.
One of my accomplishments that year was to institute a
new political action committee.
In 1986, I moved across town to Cedars-Sinai Medical
Center to become chair of Pediatrics and build a new Med-
ical Genetics Center in partnership with Jerry Rotter. I
joined forces with the geneticists at the UCLA Campus
and Harbor-UCLA and created the UCLA Intercampus Med-
ical Genetics Training Program, which has trained scores
of excellent clinical and laboratory geneticists.
At the turn of the decade, I was asked by the ASHG to
form a clinically oriented organization, as they wanted to
concentrate on genetics research. The laboratory directors
were feeling disenfranchised at that time and were plan-
ning to form their own guild. I assembled a group of lead-
ers in the field and, with the help of Mike Watson, drafted
a constitution for the American College of Medical Ge-
netics (ACMG) and its Foundation, making the College
equally responsive to the needs of clinicians and lab peo-
ple. We applied for membership in the Council of Medical
Specialty Societies and became the 24th recognized med-
ical specialty. We instituted an annual meeting, and, to
avoid too many meetings each year, we combined the
ACMG meeting with the ongoing March of Dimes (MOD)
meeting and changed the time to the spring—6 months
around the calendar from the ASHG meetings.
The ABMS finally admitted the ABMG as the first new
board in 20 years, and as a full specialty. However, non-
doctoral individuals were not eligible for ABMS member-
ship, and we had to spin off the American Board of Genetic
Counselors (ABGC). In order to maintain partnership and
full integration with the genetic counselors, we formed the
Council of Medical Genetics Organizations (COMGO)—the
initial group being presidents of the ASHG, ABMG, ACMG,
National Society of Genetic Counselors (NSGC), and the
ABGC. We also helped fund the new ABGC.
The ACMG Foundation (ABMGF) was created to fund
raise for education. We formed the Industry Liaison Coun-
cil, hoping to attract diagnostic and therapeutic compa-
nies involved in genetic disease, to help them in setting
policy and gain their financial support. Rodney Howell
expanded this function greatly during his presidency, and
the Foundation coffers have increased considerably. Mike
Watson was hired as executive director of ACMG and
immediately set off to grow the College’s influence and
finances.
There are a number of burning issues today facing med-
ical genetics: How many medical geneticists do we need?
How do we recruit them—with less than half of the train-
ing positions filled? We must start young—push for much
more exposure to medical students. However, medical ge-
netics is not a lucrative specialty, and recruits must be
turned on by scientific excitement. We should not bitch
and moan about the trials and tribulations of NIH funding
and reimbursement (at least in front of the students). To
save and populate our species, we must attract, seduce,
train, employ, and sustain our youth!
It is curious that the so-called yuppie specialties that
have attracted many of the top medical students in the
past decade because of their income potential all start with
a vowel! I think that is the reason that radiology changed
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its name to “imaging.” Perhaps we ought to change our
name from genetics to “inheritology.”
Do we remain as generalists? Should we be consul-
tants or primary-care docs? We can’t claim the genome as
our territory. It is now part of every specialty of medicine.
Can we hold off the commercial labs? Why should we
be any more successful at this than the endocrinologists
and immunologists, which were once lab-based academic
specialties?
There is no way that generalist medical geneticists will
be able to serve the increasing needs of society in provid-
ing genetics services for all diseases. I believe that we
should create joint training programs with other special-
ties, such as perinatologists, neurologists, and clinical on-
cologists—similar to the new molecular medicine certifi-
cate with the pathologists. One year of specialized training
is better than none; for example, most perinatologists now
do prenatal diagnosis without any genetics training. The
ABMG used to offer perinatologists credit for one year of
research training in perinatology, and thus they could sit
for their clinical genetics boards with only 1 year of ge-
netics fellowship. This type of joint program with other
boards, whereby one can save a year in obtaining dual
certification, should be explored! Our goal should be to
ensure that genetics services are available to everyone—
and not just attempt to preserve our species.
We should take advantage of ethnic differences in ge-
netics. The Tay-Sachs program made major changes in dis-
ease prevalence and has served as the model for greatly
reducing the prevalence of thalessemia in Sardinia. Little
else has been done in this regard. This should be true for
common diseases as well—BRCA testing in Ashkenazi Jews
costs 20% of what it does in other ethnic groups, since
we can pinpoint three major mutations rather than have
to sequence the entire gene. We should detail genomic
differences between all ethnic groups and utilize this in-
formation for early detection and prevention of disease
and improved personalized medicine. Let us celebrate our
differences rather than hide behind a politically correct
cloak. We are currently developing such a multicultural
genetics center at Cedars-Sinai.
We are entering a new age where all medicine will use
genetic methodology. If we do our job properly, all future
M.D.s will be conversant in genetics and genomics and
able to interpret molecular lab results effectively. We should
stay at the forefront of our science—discovering new
knowledge, developing new technology, and hoping that
it gets disseminated throughout academic medicine, pri-
vate medical practice, and industry, so that we are always
ready to take on new challenges and not be burdened by
what has become routine.
So what are the lessons I have learned over these 50-
plus years?
1. Choose the right mentors.
2. Never let specialty boundaries deter you.
3. If your original plan doesn’t work out, immediately
bounce back and take the next fork in the road.
4. Set your sights high—if you don’t aim for the sun,
you will never get to the moon.
5. Treat your students and staff with respect and they
will be glad to help you attain your goals.
6. Choose the best people to work with—hope that they
all outshine you, and you can take credit for the in-
tegrated finished product.
7. Nothing stays the same—don’t try to preserve the
old tried-and-true methods, but let someone else take
them over and shoot for the next level.
8. Be lucky in love, cherish and take pride in your spouse
and children, and don’t let your job or ambitions
interfere with a happy family life.
This award is a great honor, and I have many people to
thank—my mentors Clarke Fraser and Victor McKusick;
my dear friend and partner Mike Kaback; the many people
who helped me form the board and college, especially
Mike Watson and Kurt Hirschhorn; my skeletal dysplasia
team, including Dan Cohn, Bill Wilcox, and Debbie Kra-
kow, who have kept me from becoming a dinosaur; and
especially my wonderful wife, Ann, who is clearly the
wind beneath my wings.
